World's Best Scientists 2026 revealed!
Takeshi Kurata

Takeshi Kurata

D-Index & Metrics

Immunology

D-Index
76
Citations
21961
World Ranking
1906
National Ranking
75

Takeshi Kurata publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Takeshi Kurata sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 359 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Takeshi Kurata D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Takeshi Kurata sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Takeshi Kurata is affiliated with Juntendo University in Japan, contributing extensively to research in the field of medicine, particularly focusing on oncology and pulmonary and respiratory medicine. Their work spans multiple subfields including molecular biology, epidemiology, and surgery, with a strong emphasis on lung cancer and cancer immunotherapy.

The main topics covered in Kurata's research include:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Research Studies
  • Gastric Cancer Management and Outcomes
  • Neuroendocrine Tumor Research Advances

Kurata has published extensively, with a notable presence in several key oncology journals. The most frequent publication venues are:

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Annals of Oncology
  • Cancer Science
  • Haigan

Recent significant papers authored by Kurata include:

  • Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer (2020), Journal of Clinical Oncology
  • Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study (2023), Journal of Clinical Oncology
  • Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial (2021), Journal of Thoracic Oncology
  • Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189 (2021), Annals of Oncology
  • Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407 (2021), Journal of Thoracic Oncology

Kurata frequently collaborates with several co-authors, including:

  • Hiroshige Yoshioka
  • Yuta Yamanaka
  • Nobuyuki Yamamoto
  • Yuki Takeyasu
  • Marina Chiara Garassino

Best Publications

  • Identification of human herpesvirus-6 as a causal agent for exanthem subitum

    Koichi Yamanishi;Kimiyasu Shiraki;Toshio Kondo;Toshiomi Okuno

  • Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G.

    Takaya Gotoh;Seisuke Hattori;Shun Nakamura;Hitoshi Kitayama

  • DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane.

    Hideki Hasegawa;Etsuko Kiyokawa;Shinya Tanaka;Kazuo Nagashima

  • Transgenic mice susceptible to poliovirus

    Satoshi Koike;Choji Taya;Takeshi Kurata;Shinobu Abe

  • Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection

    Takeshi Ichinohe;Izumi Watanabe;Izumi Watanabe;Satoshi Ito;Satoshi Ito;Hideki Fujii

  • Two species of human CRK cDNA encode proteins with distinct biological activities.

    Michiyuki Matsuda;Shinya Tanaka;Satoshi Nagata;Asato Kojima

  • Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I

    Hideki Hasegawa;Hirofumi Sawa;Martha J Lewis;Martha J Lewis;Yasuko Orba

  • Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.

    Harutaka Katano;Yuko Sato;Takeshi Kurata;Shigeo Mori

  • Defense mechanisms against influenza virus infection in the respiratory tract mucosa.

    Unknown

  • Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

    Yasuko Asahi;Tomoki Yoshikawa;Izumi Watanabe;Takuya Iwasaki

  • Human herpesvirus 6 infection in renal transplantation.

    Toshiomi Okuno;Kazuhiro Higashi;Kimiyasu Shiraki;Koichi Yamanishi

  • CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells.

    Michiyuki Matsuda;Yuko Hashimoto;Kenkoh Muroya;Hideki Hasegawa

  • All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition

    Masanobu Kinomoto;Takayuki Kanno;Mari Shimura;Yukihito Ishizaka

  • Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection.

    Y Asano;T Yoshikawa;Y Kajita;R Ogura

  • Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan

    Paul Keim;Kimothy L. Smith;Christine Keys;Hiroshi Takahashi

  • Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.

    Ze Chen;Kazutoshi Matsuo;Hideki Asanuma;Hidehiro Takahashi

  • Isolation and characterization of mouse nasal-associated lymphoid tissue.

    Unknown

  • Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

    Unknown

  • Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.

    Unknown

  • Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.

    Yasuko Asahi-Ozaki;Tomoki Yoshikawa;Yoichiro Iwakura;Yujiro Suzuki

  • Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

    Takeshi Ichinohe;Shin-Ichi Tamura;Akira Kawaguchi;Akira Kawaguchi;Akira Kawaguchi;Ai Ninomiya

  • Isolation of Borna Disease Virus from Human Brain Tissue

    Yurie Nakamura;Hirokazu Takahashi;Yuko Shoya;Takaaki Nakaya

  • Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

    Ze Chen;Shin-etsu Kadowaki;Yukari Hagiwara;Tomoki Yoshikawa

  • Bacillus anthracis incident, Kameido, Tokyo, 1993.

    Hiroshi Takahashi;Paul Keim;Arnold F. Kaufmann;Christine Keys

  • Cross‐protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules

    Unknown

Frequent Co-Authors

Tetsutaro Sata
Tetsutaro Sata National Institute of Infectious Diseases
Hideki Hasegawa
Hideki Hasegawa National Institutes of Health
Michiyuki Matsuda
Michiyuki Matsuda Kyoto University
Kazuo Nagashima
Kazuo Nagashima Hokkaido University
Hirofumi Sawa
Hirofumi Sawa Hokkaido University
Koichi Yamanishi
Koichi Yamanishi Osaka University
Shigeru Morikawa
Shigeru Morikawa National Institutes of Health
Harutaka Katano
Harutaka Katano National Institutes of Health
William W. Hall
William W. Hall University College Dublin
Tetsushi Yoshikawa
Tetsushi Yoshikawa Fujita Health University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining immunology with clinical practice, pursuing nursing degrees online offers flexible pathways. Programs like the 12-month accelerated nursing programs allow students with prior degrees to swiftly transition into nursing roles, supporting a deeper understanding of immune-related health conditions.

If you are starting your nursing journey, consider the lpn programs with easiest admission requirements. These programs provide an accessible entry point into patient care, which is crucial for those aiming to specialize in immunology-focused healthcare services.

For advanced clinical roles, exploring the easiest nurse practitioner program can be a strategic step. Nurse practitioners with immunology knowledge play vital roles in diagnosing and managing diseases related to the immune system.

Mental health is interlinked with immune function, making top pmhnp programs an excellent choice for those aiming to specialize in psychiatric-mental health nursing while applying immunological insights to patient care.

Best Scientists Citing Takeshi Kurata

Trending Scientists

Recently Published Articles